Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes

R. A. De Fronzo, C. F. Burant, P. Fleck, C. Wilson, Q. Mekki, R. E. Pratley

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology